Agenda

Introduction
Let's get on the path of biosimilar drug development!
16:00
Introduction
Anton Franken MD PhD
EU biosimilar development pathway: overview.

Anton A.M. Franken MD, PhD

Speaker
16:05
EU biosimilar development pathway: overview.
Michal Nowicki MD
Translating the biosimilar development pathway into practical execution in healthy volunteer studies.

Michal Nowicki MD, MPharm

Speaker
16:30
Translating the biosimilar development pathway into practical execution in healthy volunteer studies.
moderators
Q&A session

Agnieszka Kulesza & Ronald Koning

Host & Moderator
16:45
Q&A session

To ensure the best possible experience, the website contains cookies. Please read our privacy policy.